Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Terminated2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00439218Phase 1/2Terminated
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I
Spinal Muscular Atrophy Type I
Principalinvestigator
NCT00439569Phase 1/2Terminated
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
Spinal Muscular Atrophy Type IISpinal Muscular Atrophy Type III
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sitra Tauscher-Wisniewski, MD

Novartis Gene Therapies, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type IMuscular Atrophy, Spinal, Type IIJuvenile Spinal Muscular Atrophy
Similarity Score30%

Peter R. Gilbert, ScM

National Institute of Neurological Disorders and Stroke, Program Director

Related
1 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal, Type IIJuvenile Spinal Muscular Atrophy

Worked with same sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)Westat
Collaborated on 1 trial
Similarity Score24%

Leonard FEASSON, MD PhD

Centre Hospitalier Universitaire de Saint Etienne

Related
3 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type IJuvenile Spinal Muscular Atrophy
Similarity Score20%

Megan A Iammarino, DPT

Nationwide Children's Hospital

Related
1 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type IMuscular Atrophy, Spinal, Type II
Similarity Score20%

Peter R Gilbert, ScM

The National Institute of Neurological Disorders and Stroke

Related
1 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type I

Worked with same sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)Westat
Collaborated on 1 trial
Similarity Score14%

Nour Maalouf, Psychomotor Therapist DE

Paediatric neurological and intentive care unity, Raymond Poincaré Hospital - APHP

Related
1 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type I
Similarity Score10%

Isabelle Desguerre, MD, PhD

Necker Hospital

Related
1 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type I
Similarity Score10%

Thomas O. Crawford, MD

Johns Hopkins University

Related
1 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal, Type II
Similarity Score10%

Kun Sun, Doctor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Related
1 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type I
Similarity Score10%

Enrico Bertini, MD

Bambino Gesu Hospital

Related
1 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal, Type II
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00439218Phase 1/2PrincipalInvestigator

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I

Spinal Muscular Atrophy Type I
Terminated
NCT00439569Phase 1/2PrincipalInvestigator

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III

Spinal Muscular Atrophy Type IISpinal Muscular Atrophy Type III
Terminated

All 2 trials loaded